SCHEMBL4556597

SCHEMBL4556597

CC(=O)On1nnc2c(Oc3cc(Cl)cc(C#N)c3)c(Cl)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.39
KCNH2 Q12809 2/20 0.39
EPAS1 Q99814 2/20 0.34
VEGFA P15692 1/20 0.34
HDAC3 O15379 2/20 0.33
HDAC4 P56524 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC7 Q8WUI4 2/20 0.33
HDAC2 Q92769 2/20 0.33
HDAC10 Q969S8 2/20 0.33
HDAC11 Q96DB2 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
HDAC6 Q9UBN7 2/20 0.33
HDAC9 Q9UKV0 2/20 0.33
HDAC5 Q9UQL6 2/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
ARNT P27540 1/20 0.32
RORC P51449 1/20 0.32
RARG P13631 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2885704 0.80 CYP3A4 (0.40) CYP3A4KCNH2EPAS1VEGFACYP2C9
SCHEMBL2881238 0.79 CYP3A4 (0.37) CYP3A4KCNH2EPAS1VEGFACYP2C9
SCHEMBL2878137 0.78 KCNH2 (0.40) CYP3A4KCNH2EPAS1VEGFACYP2C9
SCHEMBL2883932 0.76 PTGS2 (0.39) CYP3A4KCNH2HDAC8RORCRARG
SCHEMBL13079320 0.76 CNR1 (0.38) CYP3A4KCNH2
SCHEMBL2885454 0.76 CYP3A4 (0.36) CYP3A4KCNH2EPAS1VEGFACYP2C9
SCHEMBL2883066 0.75 PDE8B (0.45) CYP3A4KCNH2
SCHEMBL2885434 0.74 KMT2A (0.39) RORC
SCHEMBL13078696 0.74 ALDH1A1 (0.45) CYP3A4KCNH2CYP2C9CYP2C19RORC
SCHEMBL2885453 0.73 CYP3A4 (0.36) CYP3A4KCNH2CYP2C9CYP2C19RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121638-A2 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS Merck & Co., Inc. (US) 2009-11-25 EP disclosed
WO-2008076225-A2 NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MERCK & CO., INC. (US) 2008-06-26 WO disclosed